DuPont de Nemours, Inc. ((DD)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
DuPont de Nemours struck an upbeat tone on its latest earnings call, pointing to a solid start to FY2026 with growth across sales, margins, and earnings. Management acknowledged ongoing geopolitical and cost headwinds but emphasized that disciplined execution, innovation investments, and active pricing actions are driving outperformance and supporting a higher full‑year outlook.
Top-Line Growth and Upgraded Sales Outlook
DuPont reported Q1 net sales of $1.7 billion, up 4% year over year, with 2% organic growth and a 2% currency boost. Management now guides Q2 sales to about $1.8 billion and has lifted full‑year sales guidance to roughly $7.185 billion at the midpoint, adding $80 million versus the prior forecast.
Margin and EBITDA Expansion Underpin Profit Story
Operating EBITDA climbed 15% in Q1 to $414 million, pushing the EBITDA margin to 24.6%, up 230 basis points from a year ago. On a pro forma basis EBITDA rose 10% with roughly 130 basis points of margin expansion, underscoring better mix, productivity gains, and cost discipline.
EPS Upside and Higher Full-Year Earnings Targets
Adjusted EPS of $0.55 surged 53% year over year, with pro forma EPS growth of 20%, marking clear outperformance versus prior expectations. Reflecting this momentum, DuPont raised its full‑year adjusted EPS range to $2.35–$2.40, implying about 40% reported and mid‑teens pro forma growth.
Cash Generation, Divestiture Proceeds, and Buybacks
Transaction‑adjusted free cash flow reached $147 million in Q1, with 65% conversion, and management reiterated a goal of over 90% for the full year. The company also launched a $275 million accelerated share repurchase under its $2 billion program and completed the Aramids sale, generating about $1.1 billion in net proceeds.
Healthcare & Water Delivers Standout Performance
Healthcare & Water posted net sales of $806 million, a 6% year‑over‑year increase driven by 3% organic growth and 3% currency support. Healthcare organic sales rose at a high single‑digit pace, while segment EBITDA grew 9% and margins improved to 30.3%, up 110 basis points.
Diversified Industrials Shows Resilience
Diversified Industrials net sales reached $875 million, up 3% with currency adding roughly three points and organic sales essentially flat. Operating EBITDA advanced 8% with margin expanding to 22.9%, helped by strength in automotive battery adhesives and aerospace despite softness in other end markets.
Operational Improvements and Innovation Drive Efficiency
Management highlighted gains in asset reliability and equipment effectiveness, supported by Kaizen events and tighter process discipline across plants. The company’s Vitality Index sits 35% above its prior benchmark, and new digital and AI tools are being used to speed R&D and optimize maintenance and planning.
Pricing and Cost Actions to Offset Input Inflation
DuPont has identified about $90 million of incremental input costs tied partly to Middle East conflict and is deploying pricing and surcharges to fully offset these over the year. The company expects roughly $25 million of price benefit in Q2, building to a full run‑rate impact in the second half.
Middle East Logistics Disruption Remains a Watch Point
Logistics issues connected to Middle East tensions prevented shipment of around $10 million of water‑related sales in Q1, creating a modest drag. DuPont’s total revenue exposure to the region is about $300 million, and management’s base case assumes disruption continues through 2026, with mitigation measures ongoing.
Input Costs, Mix, and Currency Pressure Margins
Beyond logistics, the company faces roughly $90 million in higher raw material and energy costs, leading to an expected 30 basis‑point margin headwind in Q2 from timing between price and cost. Mix shifts should add another 40 basis points of pressure from Q1 to Q2, while a stronger U.S. dollar trims the anticipated currency benefit to less than 1% for the year.
Construction Market Weakness Weighs on Growth
Building technologies saw low‑single‑digit organic sales declines in Q1 as construction markets stayed soft, particularly for certain building applications. This weakness contributed to flat organic sales in Diversified Industrials and remains a drag on otherwise improving industrial demand.
Packaging and Printing Still Under Pressure
The company continues to face challenges in printing and some packaging lines, reflecting reduced home and office print usage and tough comparisons in certain packaging niches. Management nevertheless expects packaging to recover to low‑single‑digit growth for the full year as demand normalizes.
Stranded Costs and Cash Conversion Progress
DuPont is working through about $30 million of stranded costs from its recent separation, targeting full elimination within two years and a $10 million reduction in the run‑rate this year. Although Q1 free cash flow conversion of 65% trails the full‑year target, leadership expects a stronger second half and says it is on track with its cost and cash plans.
Geopolitical and Execution Risks Still in Focus
Management’s outlook assumes current Middle East conditions and commodity prices remain broadly stable, but further escalation could disrupt supply chains and logistics beyond current mitigation. Investors were reminded that while risk controls are in place, geopolitical volatility and execution around pricing and costs remain key swing factors for results.
Upgraded 2026 Outlook Signals Confidence
After a strong Q1, DuPont raised its 2026 guidance, calling for Q2 net sales of about $1.8 billion, operating EBITDA near $430 million, and adjusted EPS of $0.59. For the full year, the company now targets roughly $7.185 billion of sales with about 4% organic growth, $1.745 billion in operating EBITDA, adjusted EPS of $2.35–$2.40, and free cash flow conversion above 90% despite cost and currency headwinds.
DuPont’s earnings call painted the picture of a portfolio gaining traction, with healthcare, water, and selected industrial applications offsetting pockets of weakness in construction and printing. While geopolitical and cost uncertainties linger, rising margins, higher EPS guidance, and stepped‑up capital returns suggest management is executing well and sees further upside in 2026 performance.